Mary F Paine

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 22

Top Venues

Drug metabolism and disposition: the biological fate of chemicals

Pharmaceutics

Clinical and translational science

Clinical pharmacology and therapeutics

Washington State University - Spokane

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Washington State University - Spokane Aug 01 2013

United States

Associate Professor :: Pharmaceutical Sciences

Publications

Kshitee Kharve, Andrew S Engley, Mary F Paine, Jason A Sprowl
Impact of Drug-Mediated Inhibition of Intestinal Transporters on Nutrient and Endogenous Substrate Disposition…an Afterthought? Pharmaceutics 16 (4) (2024)
Kshitee Kharve, Andrew S Engley, Mary F Paine, Jason A Sprowl
Impact of Drug-Mediated Inhibition of Intestinal Transporters on Nutrient and Endogenous Substrate Disposition…an Afterthought? Pharmaceutics 16 (4) (2024)
Kshitee Kharve, Andrew S Engley, Mary F Paine, Jason A Sprowl
Impact of Drug-Mediated Inhibition of Intestinal Transporters on Nutrient and Endogenous Substrate Disposition…an Afterthought? Pharmaceutics 16 (4) (2024)
Kshitee Kharve, Andrew S Engley, Mary F Paine, Jason A Sprowl
Impact of Drug-Mediated Inhibition of Intestinal Transporters on Nutrient and Endogenous Substrate Disposition…an Afterthought? Pharmaceutics 16 (4) (2024)
Victoria O Oyanna, Kenisha Y Garcia-Torres, Baron J Bechtold, Katherine D Lynch, M Ridge Call, Miklós Horváth, Preston K Manwill, Tyler N Graf, Nadja B Cech, Nicholas H Oberlies, Mary F Paine, John D Clarke
Goldenseal-mediated inhibition of intestinal uptake transporters decreases metformin systemic exposure in mice. Drug metabolism and disposition: the biological fate of chemicals (2023)
James T Nguyen, Dan-Dan Tian, Rakshit S Tanna, Christopher M Arian, Justina C Calamia, Allan E Rettie, Kenneth E Thummel, Mary F Paine
An Integrative Approach to Elucidate Mechanisms Underlying the Pharmacokinetic Goldenseal-Midazolam Interaction: Application of In Vitro Assays and Physiologically Based Pharmacokinetic Models to Understand Clinical Observations. The Journal of pharmacology and experimental therapeutics (2023)
Rakshit S Tanna, Nadja B Cech, Nicholas H Oberlies, Allan E Rettie, Kenneth E Thummel, Mary F Paine
Translating kratom-drug interactions: from bedside to bench and back. Drug metabolism and disposition: the biological fate of chemicals (2023)
Xiaotong Li, Patrick Ndungu, Sanya B Taneja, Maryann R Chapin, Susan B Egbert, Krishi Akenapalli, Mary F Paine, Sandra L Kane-Gill, Richard David Boyce
An evaluation of adverse drug reactions and outcomes attributed to kratom in the US Food and Drug Administration Adverse Event Reporting System from January 2004 through September 2021. Clinical and translational science (2023)
Xiaotong Li, Patrick Ndungu, Sanya B Taneja, Maryann R Chapin, Susan B Egbert, Krishi Akenapalli, Mary F Paine, Sandra L Kane-Gill, Richard David Boyce
An evaluation of adverse drug reactions and outcomes attributed to kratom in the US Food and Drug Administration Adverse Event Reporting System (FAERS) from January 2004 through September 2021. Clinical and translational science (2023)
Sumit Bansal, C Austin Zamarripa, Tory R Spindle, Elise M Weerts, Kenneth E Thummel, Ryan Vandrey, Mary F Paine, Jashvant D Unadkat
Evaluation of Cytochrome P450-Mediated Cannabinoid-Drug Interactions in Healthy Adult Participants. Clinical pharmacology and therapeutics (2023)
John D Clarke, Sabrina M Judson, Dan-Dan Tian, Trevor O Kirby, Rakshit S Tanna, Adrienn Matula-Péntek, Miklós Horváth, Matthew E Layton, John R White, Nadja B Cech, Kenneth E Thummel, Jeannine S McCune, Danny D Shen, Mary F Paine
Co-consuming green tea with raloxifene decreases raloxifene systemic exposure in healthy adult participants. Clinical and translational science (2023)
Xiaotong Li, Patrick Ndungu, Sanya B Taneja, Maryann R Chapin, Susan B Egbert, Krishi Akenapalli, Mary F Paine, Sandra L Kane-Gill, Richard David Boyce
An evaluation of adverse drug reactions and outcomes attributed to kratom in the US Food and Drug Administration Adverse Event Reporting System (FAERS) from January 2004 through September 2021. Clinical and translational science (2023)
Rakshit S Tanna, James T Nguyen, Deena L Hadi, Matthew E Layton, John R White, Nadja B Cech, Nicholas H Oberliels, Allan E Rettie, Kenneth E Thummel, Mary F Paine
Clinical assessment of the drug interaction potential of the psychotropic natural product kratom. Clinical pharmacology and therapeutics (2023)
Sumit Bansal, Mayur K Ladumor, Mary F Paine, Jashvant D Unadkat
A physiologically-based pharmacokinetic model for cannabidiol in healthy adults, hepatically-impaired adults, and children . Drug metabolism and disposition: the biological fate of chemicals (2023)
Rakshit S Tanna, James T Nguyen, Deena L Hadi, Preston K Manwill, Laura Flores-Bocanegra, Matthew E Layton, John R White, Nadja B Cech, Nicholas H Oberliels, Allan E Rettie, Kenneth E Thummel, Mary F Paine
Clinical Pharmacokinetic Assessment of Kratom ( Mitragyna speciosa ), a Botanical Product with Opioid-like Effects, in Healthy Adult Participants. Pharmaceutics 14 (3) (2022)
Kunal S Taskar, Xinning Yang, Sibylle Neuhoff, Mitesh Patel, Kenta Yoshida, Mary F Paine, Kim L R Brouwer, Xiaoyan Chu, Yuichi Sugiyama, Jack Cook, Joseph W Polli, Imad Hanna, Yurong Lai, Maciej Zamek-Gliszczynski, null null
Clinical Relevance of Hepatic and Renal P-gp/BCRP Inhibition of Drugs: An International Transporter Consortium Perspective. Clinical pharmacology and therapeutics 112 (3) (2022)
Shawn Herring, Jessica M Oda, Jessica Wagoner, Delaney Kirchmeier, Aidan O'Connor, Elizabeth A Nelson, Qinfeng Huang, Yuying Liang, Lisa Evans DeWald, Lisa M Johansen, Pamela J Glass, Gene G Olinger, Aleksandr Ianevski, Tero Aittokallio, Mary F Paine, Susan L Fink, Judith M White, Stephen J Polyak
Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs. Antimicrobial agents and chemotherapy 65 (4) (2021)
Emily J Cox, Dan-Dan Tian, John D Clarke, Allan E Rettie, Jashvant D Unadkat, Kenneth E Thummel, Jeannine S McCune, Mary F Paine
Modeling Pharmacokinetic Natural Product-Drug Interactions for Decision-Making: A NaPDI Center Recommended Approach. Pharmacological reviews 73 (2) (2021)
Shawn Herring, Jessica M Oda, Jessica Wagoner, Delaney Kirchmeier, Aidan O'Connor, Elizabeth A Nelson, Qinfeng Huang, Yuying Liang, Lisa Evans DeWald, Lisa M Johansen, Pamela J Glass, Gene G Olinger, Aleksandr Ianevski, Tero Aittokallio, Mary F Paine, Susan L Fink, Judith M White, Stephen J Polyak
Erratum for Herring et al., "Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs". Antimicrobial agents and chemotherapy 65 (6) (2021)
Matthew G McDonald, Dan-Dan Tian, Kenneth E Thummel, Mary F Paine, Allan E Rettie
Modulation of Major Human Liver Microsomal Cytochromes P450 by Component Alkaloids of Goldenseal: Time-Dependent Inhibition and Allosteric Effects. Drug metabolism and disposition: the biological fate of chemicals 48 (10) (2020)
Dan-Dan Tian, Cathrine Leonowens, Emily J Cox, Vanessa González-Pérez, Kosea S Frederick, Yolanda V Scarlett, Michael B Fisher, Mary F Paine
Indinavir Increases Midazolam N-Glucuronidation in Humans: Identification of an Alternate CYP3A Inhibitor Using an In Vitro to In Vivo Approach. Drug metabolism and disposition: the biological fate of chemicals 47 (7) (2019)
Michelle L Montonye, Dan-Dan Tian, Tarana Arman, Katherine D Lynch, Bruno Hagenbuch, Mary F Paine, John D Clarke
A Pharmacokinetic Natural Product-Disease-Drug Interaction: A Double Hit of Silymarin and Nonalcoholic Steatohepatitis on Hepatic Transporters in a Rat Model. The Journal of pharmacology and experimental therapeutics 371 (2) (2019)

Mary F Paine.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mary F Paine